Skip to main content
SpringerLink
Log in

Male Breast Cancer

  • Chapter
  • First Online:
Breast Cancer Epidemiology

  • 3011 Accesses

Abstract

The aim of studying the epidemiology of breast cancer is to identify risk factors that could be eliminated or inhibited. Unfortunately, the two major risk factors are gender and increasing age, neither of which can be avoided. Nevertheless, the relative rarity of male breast cancer (MBC) has prompted investigations in the hope that the disease in men can give clues to the etiology of the more common female form. One of the evident differences is the age frequency distribution of the disease: in women it is bimodal, with peaks at 52 and 71 years whereas in MBC it is unimodal, peaking at age 71 (Anderson et al. 2004). In a recent report from the Veterans’ Affairs Central Cancer Registry the mean age at diagnosis for females with breast cancer was 57 whereas for men it was 67 (Nahleh et al. 2007). The clinical behavior of MBC is similar to that of postmenopausal breast cancer in women (Fentiman et al. 2006).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Amir H, Kaaya EE, Kwesigabo G, Kiitinya JN (2000) Breast cancer before and after the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1968 to 1996. J Natl Med Assoc 92:301–305

    CAS  PubMed  Google Scholar 

  • Andersen JA, Gram JB (1982) Male breast at autopsy. Acta Pathol Microbiol Immunol Scand 90(3):191–197

    CAS  Google Scholar 

  • Anderson WF, Althuis MD, Brinton LA et al (2004) Is male breast cancer similar or different from female breast cancer? Br Cancer Res Treat 83:77–86

    Google Scholar 

  • Auvinen A, Curtis RE, Ron E (2002) Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94:1330–1332

    PubMed  Google Scholar 

  • Ballerina P, Recchione C, Cavalleri A et al (1990) Hormones in male breast cancer. Tumori 76:26–28

    Google Scholar 

  • Basham VM, Lipscombe JM, Ward JM et al (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Br Cancer Res 4:R2

    CAS  Google Scholar 

  • Benchellal Z, Wagner A, Harchaoui Y et al (2002) Male breast cancer: 19 case reports. Ann Chir 127:619

    CAS  PubMed  Google Scholar 

  • Bernstein L, Depue RH, Ross RK et al (1986) Higher maternal levels of free estradiol in first compared with second pregnancy: early gestational differences. J Natl Cancer Inst 76:1035–1039

    CAS  PubMed  Google Scholar 

  • Bhagwandin S (1972) Carcinoma of the male breast in Zambia. East Afr Med J 49:176–179

    Google Scholar 

  • Bhatia S, Robison LL, Oberlin O et al (1996) Breast cancer and other second neoplasms after childhood Hodgkin’s disease. N Engl J Med 334:745–751

    CAS  PubMed  Google Scholar 

  • Brainard GC, Kavet R, Keiferts LI (1999) The relationship between electromagnetic field and light exposures by melatonin and breast cancer risk. J Pineal Res 26:65–100

    CAS  PubMed  Google Scholar 

  • Calabresi E, De Giull A, Becchiolini A et al (1976) Plasma estrogens and androgens in male breast cancer. J Steroid Biochem 7:603–609

    Google Scholar 

  • Carey AH, Waterworth D, Patel K et al (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873–1876

    CAS  PubMed  Google Scholar 

  • Carlsson G, Hafstrom L, Jonsson P (1981) Male breast cancer. Clin Oncol 7:149–155

    CAS  PubMed  Google Scholar 

  • Casagrande JT, Hanisch R, Pike MC et al (1988) A case-control study of male breast cancer. Cancer Res 48:1326–1330

    CAS  PubMed  Google Scholar 

  • Cerhan JR, Kushi LH, Losom JE et al (2000) Twinship and risk of post-menopausal breast cancer. J Natl Cancer Inst 92:261–265

    CAS  PubMed  Google Scholar 

  • Chamberlain NL, Driver ED, Miesfeld RI (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181–3186

    CAS  PubMed  Google Scholar 

  • Chodick G, Struewing JP, Ron E et al (2008) Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence fromj 261 cases in Israel, 1976–1999. Eur J Med Genet 51:141–147

    PubMed  Google Scholar 

  • Coard K, McCartney T (2004) Bilateral synchronous carcinoma of the male breast in a patient receiving estrogen therapy for carcinoma of the prostate: cause or coincidence? South Med J 97:308–310

    PubMed  Google Scholar 

  • Cocco P, Figgs L, Dosemeci M et al (1998) Case-control study of occupational exposures and male breast cancer. Occup Environ Med 55:599–604

    CAS  PubMed  Google Scholar 

  • D’Avanzo B, La Vecchia C (1995) Risk factors for male breast cancer. Br J Cancer 71:1359–1362

    PubMed  Google Scholar 

  • De Jong MM, Nolte IM, te Meerman GJ et al (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39:225–242

    PubMed  Google Scholar 

  • Demers PA, Thomas DB, Rosenblatt KA (1991) Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol 134:340–347

    CAS  PubMed  Google Scholar 

  • Donegan WL, Redlich PN, Lang PG, Gall MT (1998) Carcinoma of the breast in males. A multiinstitutional survey. Cancer 83:498–509

    CAS  PubMed  Google Scholar 

  • Dong C, Hemminki K (2001) Second primary breast cancer in men. Br Cancer Res Treat 66:171–172

    CAS  Google Scholar 

  • Ewertz M, Holmberg L, Tretli S et al (2001) Risk factors for male breast cancer – a case-control study from Scandinavia. Acta Oncol 40:467–471

    CAS  PubMed  Google Scholar 

  • Fackenthal JD, Marsh DJ, Richardson AL et al (2001) Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 38:159–164

    CAS  PubMed  Google Scholar 

  • Falchetti M, Lupi R, Rizzolo P et al (2007) BRCA1/2rerrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. Br Cancer Res Treat PMID 17661168

    Google Scholar 

  • Fentiman IS, Brame K, Chaudary MA et al (1988) Bromocriptine adjuvant treatment for operable breast cancer: a double-blind controlled pilot study. Lancet i:609–610

    Google Scholar 

  • Fentiman IS, Tirelli U, Monfardini S et al (1990) Cancer in the elderly: why so badly treated? Lancet 335:1020–1022

    CAS  PubMed  Google Scholar 

  • Fentiman IS (1998) Diagnosis and treatment of breast cancer, Chapter 19 Martin Dunitz, London

    Google Scholar 

  • Fentiman IS, Fourquet A, Hortobagyi G (2006) Male breast cancer. Lancet 367:595–601

    PubMed  Google Scholar 

  • Forloni F, Giovilli K, Pecis S et al (2001) Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old man. Endocrinol Invest 24:454–459

    CAS  Google Scholar 

  • Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490

    CAS  PubMed  Google Scholar 

  • Friedman LS, Gayther SA, Kurosaki T et al (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60:313–319

    CAS  PubMed  Google Scholar 

  • Gill S, Peston D, Vonderhaar BK, Shousha S (2001) Expression of prolactin receptors in normal, benign and malignant breast tissue: an immunological study. J Clin Pathol 54:956–960

    CAS  PubMed  Google Scholar 

  • Giordano SH, Cohen DS, Buzdae AU et al (2004) Breast carcinoma in men. A population-based study. Cancer 101:51–57

    PubMed  Google Scholar 

  • Gudmundsdottir K, Thoracius S, Jonasson JG et al (2003) CYP17 promoter polymorphism and breast cancer risk among males and females in relation to BRCA2 status. Br J Cancer 88(6):933–936

    CAS  PubMed  Google Scholar 

  • Guenel P, Cyr D, Sabroe S et al (2004) Alcohol drinking may increase the risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control 15:571–580

    PubMed  Google Scholar 

  • Haga S, Watanabe O, Shimizu T et al (1993) Breast cancer in a male patient with prolactinoma. Surg Today 23:251–255

    CAS  PubMed  Google Scholar 

  • Hansen J (2000) Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med 37:349–352

    CAS  PubMed  Google Scholar 

  • Harnden DG, Maclean N, Langlands AO (1971) Carcinoma of the breast and Klinefelter’s syndrome. J Med Gen 8:460–461

    CAS  Google Scholar 

  • Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS (2004) Male breast cancer: is the incidence increasing? Ann Surg Oncol 11:751–755

    PubMed  Google Scholar 

  • Hsing AW, McLaughlin JK, Cocco P et al (1998) Risk factors for male breast cancer (United States). Cancer Causes Control 9:269–276

    CAS  PubMed  Google Scholar 

  • Hultborn R, Hanson C, Kopf I et al (1997) Prevalence of Klinefelter’s syndrome in male breast cancer patients. Anticancer Res 17:4293–4297

    CAS  PubMed  Google Scholar 

  • Jacobs PS, Melville M, Ratcliffe S, Keay AJ, Syme J (1974) A cytogenetic survey of 11680 newborn infants. Ann Hum Genet 37:359–376

    CAS  PubMed  Google Scholar 

  • Johnson KC, Pan S, Mao Y (2002) Risk factors for male breast cancer in Canada, 1994–198. Eur J Cancer Prev 11:253–263

    CAS  PubMed  Google Scholar 

  • Jonasson JG, Agnarsson BA, Thorlacius S et al (1996) Male breast cancer in Iceland. Br J Cancer 65:446–449

    CAS  Google Scholar 

  • Kahla PB, Cassaro S, Vladimir FG et al (2005) Bilateral synchronous breast cancer in a male.Mt Sinai J Med 72:120–123

    PubMed  Google Scholar 

  • Klinefelter HG, Reifentein EC Jr, Albright F (1942) Syndrome characterized by gynecomastia, aspermatogenesis without a-Leydigism and increased secretion of follicle-stimulation hormone. J Clin Endocrinol Metab 2:615–627

    CAS  Google Scholar 

  • Lambley J, Maguire E, Lam KY (2005) Synchronous bilateral breast cancer in an elderly man. Br J 11:153

    Google Scholar 

  • La Vecchia C, Levi F, Lucchini F (1992) Descriptive epidemiology of male breast cancer in Europe. Int J Cancer 51:62–66

    PubMed  Google Scholar 

  • Lenfant-Pejovic M-H, Mlika-Cabanne N, Bouchardy C et al (1990) Risk factors for male breast cancer : a Franco-Swiss case-control study. Int J Cancer 45:661–665

    CAS  PubMed  Google Scholar 

  • Lobaccaro JM, Lumbruso S, Belon C et al (1993) Androgen receptor gene mutation in male breast cancer. Nat Genet 5:109–110

    CAS  PubMed  Google Scholar 

  • Loomis DP (1992) Cancer of breast among men in electrical occupations. Lancet 339:1482–1483

    CAS  PubMed  Google Scholar 

  • Lynge E, Afonso N, Kaerlev L et al (2005) European multicentre case-control study on risk factors for rare cancers of unknown aetiology. Eur J Cancer 41:601–612

    PubMed  Google Scholar 

  • Ma F, Fleming LE, Lee DJ et al (2005) Mortality in Florida firefighters, 1972 to 1999. Am J Ind Med 47:509–517

    PubMed  Google Scholar 

  • Mabuchi K, Bross DS, Kessler II (1985) Risk factors for male breast cancer. J Natl Cancer Inst 74:371–375

    CAS  PubMed  Google Scholar 

  • MacLean HE, Brown RW, Beilin GL, Zajac JD (2004) Increased frequency of long androgen receptor CAG repeats in male breast cancers. Br Cancer Res Treat 88:239–246

    CAS  Google Scholar 

  • Martin AM, Weber BL (2000) Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 92:1126–1135

    CAS  PubMed  Google Scholar 

  • McLaughlin JK, Malker BR, Blot WJ et al (1988) Occupational risks for male breast cancer in Sweden. Br J Indust Med 4:275–6

    Google Scholar 

  • McClure JA, Higgins CC (1951) Bilateral carcinoma of male breast after estrogen therapy. JAMA 146:7–9

    CAS  Google Scholar 

  • Meijers-Heijboer H, van den Ouweland A, Klijn J et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in non-carriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55–59

    CAS  PubMed  Google Scholar 

  • Nahleh ZA, Srikantiah R, Safa M et al (2007) Male breast cancer in the veterans affairs population: a comparative analysis. Cancer 109:1471–1477

    PubMed  Google Scholar 

  • Nirmul D, Pegoraro RJ, Jialal I et al (1982) The sex hormone profile of male patients with breast cancer. Br J Cancer 48:423–427

    Google Scholar 

  • Ohayon T, Gasl I, Baruch RG, Szabo C, Friedman E (2004) CHEK2*1100delC and male breast cancer risk in Israel. Int J Cancer 108:479–480

    CAS  PubMed  Google Scholar 

  • Ojara EA (1978) Carcinoma of the male breast in Mulago Hospital, Kampala. East Afr Med J 55:489–491

    CAS  PubMed  Google Scholar 

  • Okada K, Kajiwara S, Tanaka H, Sakamoto G (2003) Synchronous bilateral non-invasive ductal carcinoma of the male breast: a case report. Br Cancer 10:163–166

    Google Scholar 

  • Olsson H, Bladstrom A, Alm P (2002) Male gynaecomastia and risk for malignant tumours – a cohort study. BMC Cancer 2:26–31

    CAS  PubMed  Google Scholar 

  • Palli D, Masala G, Mariani-Costantini R et al (2005) A gene-environment interaction between occupation and BRCA1/BRCA2 mutations in male breast cancer. Eur J Cancer 40:2474–2479

    Google Scholar 

  • Petridou E, Glokas G, Kuper H et al (2000) Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece. Br J Cancer 83:1234–1237

    CAS  PubMed  Google Scholar 

  • Pollan M, Gustavsson P, Floderus B (2001) Breast cancer, occupation, and exposure to electromagnetic fields among Swedish men. Am J Ind Med 39:276–285

    CAS  PubMed  Google Scholar 

  • Price WH, Clayton JF, Wilson J, Collyer S, De Mey R (1985) Causes of death in X chromatin positive males (Klinefelter’s syndrome). J Epidemiol Community Health 39:330–336

    CAS  PubMed  Google Scholar 

  • Ribeiro GG, Phillips HU, Skinner LG (1980) Serum oestradiol-17β, testosterone, luteinising hormone and follicle-stimulating hormone in males with breast cancer. Br J Cancer 41:474–477

    CAS  PubMed  Google Scholar 

  • Ron E, Ikeda T, Preston DL, Tokuaka S (2005) Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst 97:603–605

    PubMed  Google Scholar 

  • Rosenblatt KA, Thomas DB, Jiminez LM et al (1999) The relationship between diet and breast cancer in men (United States). Cancer Causes Control 10:107–113

    CAS  PubMed  Google Scholar 

  • Rundle A, Tang D, Hibshoosh H et al (2000) The relationship between genetic damage from polycylic aromatic hydrocarbons in breast tissue and normal tissue. Carcinogenesis 21:1281–1289

    CAS  PubMed  Google Scholar 

  • Safram-Hoang S, Ziogas A, Anton-Culver H (2007) Risk of second primary cancer in men with breast cancer. Br Cancer Res 9:R10 (doi:b10,1186/bcr1643)

    Google Scholar 

  • Sasco AJ, Lowenfels AB, Pasker-de Jong J (1993) Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 53:538–549

    CAS  PubMed  Google Scholar 

  • Scheike O, Svenstrop B, Frandsen VA (1973) Male breast cancer II. Metabolism of oestradiol-17β in men with breast cancer. J Steroid Biochem 4:489–491

    CAS  PubMed  Google Scholar 

  • Schottenfeld D, Lilienfeld AM, Diamond H (1963) Some observations on the epidemiology of breast cancer among males. Am J Public Health 53:890–897

    CAS  Google Scholar 

  • Smith TR, Levine EA, Perrier ND et al (2003) DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12:1200–1204

    CAS  PubMed  Google Scholar 

  • Sørensen HT, Olsen ML, Mellemkjaer L et al (2005) The intrauterine origin of male breast cancer: a birth order study in Denmark. Eur J Cancer Prev 14:185–186

    PubMed  Google Scholar 

  • Steinitz R, Katz L, Ben-Hur M (1981) Male breast cancer in Israel: selected epidemiologic aspects. J Med Sci 17:816–821

    CAS  Google Scholar 

  • Swerdlow AJ, Schoemaker MJ, Higgins CD et al (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97:1204–1210

    PubMed  Google Scholar 

  • Symmers WSC (1968) Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br Med J 2:83–85

    CAS  PubMed  Google Scholar 

  • Syrjäkoski K, Hyytinen E-J, Kuukasjärvi T et al (2003) Androgen receptor gene alterations in Finnish male breast cancer.Br Cancer Res Treat 77:167–170

    Google Scholar 

  • Syrjäkoski K, Kuukasjärvi T, Auvinen A, Kallioniemi O-P (2004) CHEK2 1100delC is not a risk factor for male breast cancer population. Int J Cancer 108:475–476

    PubMed  Google Scholar 

  • Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99:1811–1814

    CAS  PubMed  Google Scholar 

  • Taylor EF, Burley VJ, Greenwood DC, Cade JE (2007) Meat consumption and risk of breast cancer in the UK Women’s Cohort Study. Br J Cancer 96:1139–1146

    CAS  PubMed  Google Scholar 

  • Tchou J, Ward MR, Volpe P et al (2007) Large genomic rearrangements in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States. Clin Breast Cancer 7:627–633

    CAS  PubMed  Google Scholar 

  • The CHEK2 Breast Cancer Consortium (2002) Low penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 and BRCA2 mutations. Nat Genet 31:55–59

    Google Scholar 

  • Thiébaut ACM, Kipnis V, Chang S-C et al (2007) Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study Cohort. J Natl Cancer Inst 99:451–462

    PubMed  Google Scholar 

  • Thomas DB, Jimenez LM, McTiernan A et al (1992) Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 135:734–748

    CAS  PubMed  Google Scholar 

  • Thomas DB, Rosenblatt K, Jiminez LM et al (1994) Ionizing radiation and breast cancer in men (United States). Cancer Causes Control 5:9–14

    CAS  PubMed  Google Scholar 

  • Thomas HV, Murphy MF, Key TJ et al (1998) Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. Ann Human Biol 25:69–75

    CAS  Google Scholar 

  • Travis R, Allen DS, Fentiman IS, Key TJ (2004) Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 96:475–482

    CAS  PubMed  Google Scholar 

  • Treves N (1958) Gynecomastia: the origins of mammary swelling in the male: an analysis of 406 patients with breast hypertrophy, 525 with testicular tumors and 13 with adrenal neoplasms. Cancer 11:1083–1102

    CAS  PubMed  Google Scholar 

  • Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero? Lancet 335:1604

    Google Scholar 

  • Tynes T, Andersen A (1990) Electromagnetic fields and male breast cancer. Lancet 336:1596

    CAS  PubMed  Google Scholar 

  • Volm MD, Talamonti MS, Thangavelu M, Gradishar WK (1997) Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol 64:74–78

    CAS  PubMed  Google Scholar 

  • Waterhouse J, Muir C, Correa P, Powell JR (eds) (1976) Cancer incidence in five continents, vol 3. IARC Sci Publ, Lyon, p 15

    Google Scholar 

  • Weiderpass E, Gridley G, Persson I et al (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71:360–363

    CAS  PubMed  Google Scholar 

  • Weiderpass E, Ye W, Adami HO et al (2001) Breast cancer risk in male alcoholics in Sweden. Cancer Causes Control 12:661–664

    CAS  PubMed  Google Scholar 

  • Whiteman DC, Murphy MF, Verkasalo PK et al (2000) Breast cancer risk in male twins: joint analysers of four twin cohorts in Denmark, Finland, Sweden and the United States. Br J Cancer 83:1231–1233

    CAS  PubMed  Google Scholar 

  • Wooster R, Mangion J, Eeles R et al (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2:132–134

    CAS  PubMed  Google Scholar 

  • Young IE, Kurian KM, Annink C et al (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81:141–143

    CAS  PubMed  Google Scholar 

  • Young IE, Kurian FM, Mackenzie MAF et al (2000a) The CAG repeat within the androgen receptor in male breast cancer patients. J Med Genet 37:139–140

    CAS  PubMed  Google Scholar 

  • Young IE, Kurian KM, Mackenzie MAF et al (2000b) A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer. Br J Cancer 82:1247–1248

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Guy’s King’s and St Thomas’ School of Medicine, Guy’s Hospital, London, UK

    Ian S. Fentiman

Authors
  1. Ian S. Fentiman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian S. Fentiman .

Editor information

Editors and Affiliations

  1. Fairview Ave. N., 1100, Seattle, 98109, U.S.A.

    Christopher Li

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Fentiman, I.S. (2010). Male Breast Cancer. In: Li, C. (eds) Breast Cancer Epidemiology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0685-4_12

Download citation

Publish with us

Policies and ethics

Search

Navigation